These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3053601)

  • 1. Steady-state evaluation of two controlled-release theophylline preparations in children.
    Tinkelman DG; Lutz CN; Crummie A; Harrison LI; McCarville SE; Bastyr MH
    J Asthma; 1988; 25(1):27-31. PubMed ID: 3053601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Theolair SR and Theo-Dur tablets.
    Domson JF; Hein EW; Sheen A; Sly RM
    Ann Allergy; 1979 Oct; 43(4):220-2. PubMed ID: 555598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous use of rapidly absorbed and sustained release theophylline preparations in children.
    Hein EW; Domson JF; Sheen A; Buffone GJ; Sly RM
    Ann Allergy; 1979 Oct; 43(4):217-9. PubMed ID: 555597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
    Menendez R; Kelly HW; Howick J; McWilliams BC
    Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a new sustained-release theophylline preparation, TheoBeads, with Theo-Dur tablets in children with asthma.
    Welch MJ; Orgel HA; Meltzer EO; Kemp JP; Gawchik S; Rooklin AR; Tinkelman DG
    J Asthma; 1988; 25(5):269-74. PubMed ID: 3182591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
    Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
    Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
    Rojanasthien N; Kovjiriyapan K; Manorot M; Pothirat C
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from intravenous to sustained-release oral theophylline in pediatric patients with asthma.
    Clarke DF; Werbowsky OL; Grodin MA; Shargel L
    Drug Intell Clin Pharm; 1986 Sep; 20(9):700-3. PubMed ID: 3757784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparative trial between two sustained-release theophylline preparations with individual doses in asthmatic in-patients.
    Van der Meer YG; Van Alphen AC; Van Altena R; Van Loenen AC
    Pharm Weekbl Sci; 1982 Dec; 4(6):183-90. PubMed ID: 6760111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state evaluation of twice-a-day dosing of a new sustained-release theophylline preparation for young children.
    Welch MJ; Kemp JP; Orgel HA; Meltzer EO
    J Asthma; 1985; 22(5):249-52. PubMed ID: 4055657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained-release theophylline for treatment of asthma in preschool children.
    Simons FE; Luciuk GH; Simons KJ
    Am J Dis Child; 1982 Sep; 136(9):790-3. PubMed ID: 7114002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent inconsistent theophylline absorption from sustained release capsules.
    Uden DL; Schaber DE; Wyatt RA
    Clin Pediatr (Phila); 1987 Jun; 26(6):285-7. PubMed ID: 3581636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of theophylline chronokinetics for asthmatic children.
    Smolensky MH; Scott PH; McGovern JP
    Prog Clin Biol Res; 1987; 227B():259-70. PubMed ID: 3628336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 12-hour and 24-hour sustained-release theophylline in outpatient management of asthma.
    Tilles DS; Hales CA
    Chest; 1987 Mar; 91(3):370-5. PubMed ID: 3816315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.
    Rogers RJ; Wiener MB; Hill MR; Szefler SJ
    Am Rev Respir Dis; 1987 Nov; 136(5):1168-73. PubMed ID: 3674579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical effect of sustained-release theophylline (Theo-Dur) for asthmatic children and serum theophylline level (author's transl)].
    Masaki T; Sekine H; Nagakura T; Iikura Y; Tomita Y; Asano T; Kajita T; Seo K
    Arerugi; 1981 Apr; 30(4):190-6. PubMed ID: 7337549
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the pharmacokinetic characteristics of slow release theophylline oral preparations in Thai children with persistent asthma.
    Trakultivakorn M; Kanthawatana S; Tontayapiwat A; Jiraporncharoen K
    Asian Pac J Allergy Immunol; 1999 Dec; 17(4):255-9. PubMed ID: 10698464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.